Selective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants.
Dendritic cells (DCs) initiate and polarize adaptive immune responses toward varying functional outcomes. By means of intravital two-photon microscopy, we report that dermal dendritic cells (DDCs) and Langerhans cells (LCs) are differentially mobilized during contact sensitization and by adjuvants such as unmethylated CpG oligonucleotide (CpG) and LPS that induce T helper type 1 (Th1) responses, or papain that induces T helper type 2 (Th2) responses. In ear pinna, contact sensitization, CpG, LPS, and papain all mobilized DDCs in three distinct phases: increased motility and dendritic probing, directed migration, and entry into lymphatic vessels. During the same treatments, the adjacent LCs in ear pinna remained immotile over a 48-hr period of observation. In contrast, footpads lacked DDCs and Th1-polarizing adjuvants selectively induced a delayed mobilization of LCs after 48 hr. Th1 polarization of CD4(+) T cells was independent of the immunization site, whereas ear immunization favored Th2 polarization, correlating with site-specific DC distribution and dynamics. Our results provide an initial description of peripheral DC dynamics in response to adjuvants and imply that LC mobilization enhances a Th1 response and is not sufficient to trigger a Th2 response, whereas mobilization of DDCs alone is sufficient to trigger T-cell proliferation and to polarize initial T-cell activation toward a Th2 response.
Sen
Debasish
D
Department of Physiology and Biophysics and Institute for Immunology, University of California, Irvine, CA 92697-4561, USA.
Forrest
Luette
L
Kepler
Thomas B
TB
Parker
Ian
I
Cahalan
Michael D
MD
D000818:Animals; D002465:Cell Movement; D016764:Cell Polarity; D049109:Cell Proliferation; D018920:Coculture Techniques; D007801:Langerhans Cells / Q000166:cytology / Q000276:immunology*; D008070:Lipopolysaccharides / Q000276:immunology; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D009838:Oligodeoxyribonucleotides / Q000276:immunology; D018417:Th1 Cells / Q000166:cytology* / Q000276:immunology*; D018418:Th2 Cells / Q000166:cytology* / Q000276:immunology*
C408982:CPG-oligonucleotide; D008070:Lipopolysaccharides; D009838:Oligodeoxyribonucleotides
Nature. 2004 Jan 8;427(6970):154-9
14712275
Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):998-1003
14722354
Nature. 2008 May 1;453(7191):51-5
18451854
Nat Immunol. 2009 Jul;10(7):706-12
19465908
Nat Rev Immunol. 2005 Aug;5(8):617-28
16056255
Histochem Cell Biol. 2008 Dec;130(6):1131-46
18987873
Am J Physiol. 1996 Jan;270(1 Pt 2):H324-9
8769768
J Exp Med. 2005 Nov 7;202(9):1271-8
16275764
Nat Immunol. 2003 Jun;4(6):579-85
12730692
J Exp Med. 2004 Oct 4;200(7):847-56
15466619
PLoS Pathog. 2008 Nov;4(11):e1000222
19043558
J Immunol. 2009 Oct 15;183(8):5085-93
19801524
Immunity. 2003 Jul;19(1):47-57
12871638
PLoS One. 2008 Sep 29;3(9):e3290
18820727
Annu Rev Immunol. 2008;26:585-626
18173372
J Immunol. 2008 Jul 1;181(1):418-30
18566408
Nat Immunol. 2002 Dec;3(12):1135-41
12415265
Nat Immunol. 2004 Dec;5(12):1243-50
15543150
J Immunol. 2008 Apr 1;180(7):4722-7
18354196
Nat Immunol. 2009 Jul;10(7):713-20
19465907
J Immunol. 2003 Nov 15;171(10):4984-9
14607893
Nat Immunol. 2009 Jul;10(7):697-705
19465906
Cell Calcium. 2001 Dec;30(6):383-93
11728133
Immunity. 2005 May;22(5):643-54
15894281
Nat Immunol. 2008 Mar;9(3):310-8
18300366
Cell. 2006 Feb 24;124(4):849-63
16497593